NCT06026488

Real-World Study of DLBCL With Different Genetic Subtypes

A Real-World Study of Diffuse Large B-Cell Lymphoma (DLBCL) Patients With Different Genetic Subtypes

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 10,000 (estimated)
• Sponsor: Ruijin Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To collect and evaluate the data of real-world treatment regimen, efficacy, safety and survival information of DLBCL patients with different genetic suptypes

Detailed description

DLBCL is a highly common malignant tumor in Asia. The aim of the study is to observe and explore the clinical information on DLBCL patients with different genetic subtypes and to analyze the clinical characteristics and prognosis of different molecular subtypes of DLBCL. This study is a non-interventional real world, observational study and all registered data are collected from real clinical practice cases. The medical data includes patient demographic, tumor characteristics, laboratory examination, history of treatments, adverse reactions, efficacy results and possible prognostic factors. The results can guide future precision therapy for DLBCL.

Conditions

• DLBCL - Diffuse Large B Cell Lymphoma
• Lymphoma

Interventions

Type	Name	Description
OTHER	Other	real world treatment and survival of DLBCL patients in China

Timeline

• Start date: 2023-10-01
• Primary completion: 2026-12-31
• Completion: 2026-12-31
• First posted: 2023-09-07
• Last updated: 2024-12-19

Locations

1 site across 1 country: China